Cargando…

Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia

Neuropsychiatric symptoms (NPS) including behavioral and psychiatric symptoms are common in the dementia stages of Alzheimer's disease (AD) and are associated with poorer outcomes in cognition, functional states, quality of life, and accelerated progression to severe dementia or death. NPS are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Kok Pin, Chiew, Hui Jin, Rosa-Neto, Pedro, Kandiah, Nagaendran, Ismail, Zahinoor, Gauthier, Serge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882863/ https://www.ncbi.nlm.nih.gov/pubmed/31824321 http://dx.doi.org/10.3389/fphar.2019.01398

Ejemplares similares

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
por: Ng, Kok Pin, et al.
Publicado: (2021)

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
por: Ng, Kok Pin, et al.
Publicado: (2017)

Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer’s disease continuum
por: Ng, Kok Pin, et al.
Publicado: (2022)

Dysfunctional mitochondrial processes contribute to energy perturbations in the brain and neuropsychiatric symptoms
por: Büttiker, Pascal, et al.
Publicado: (2023)

Frontotemporal dementia and COVID‐19: Hypothesis generation and roadmap for future research
por: Ng, Kok Pin, et al.
Publicado: (2021)

Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia
por: Hulshof, Tessa A., et al.
Publicado: (2020)

Clinical Aspects of Neurobehavioral Symptoms of Dementia
por: Yang, YoungSoon, et al.
Publicado: (2020)

Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data
por: Gill, Sascha, et al.
Publicado: (2020)

Frontotemporal Dementia in Southeast Asia: A Comparative Study
por: Tan, Yee-Leng, et al.
Publicado: (2013)

Persistence of neuropsychiatric symptoms and dementia prognostication: A comparison of three operational case definitions of mild behavioral impairment
por: Guan, Dylan X., et al.
Publicado: (2023)

Strengths and Weaknesses of the Gray Mouse Lemur (Microcebus murinus) as a Model for the Behavioral and Psychological Symptoms and Neuropsychiatric Symptoms of Dementia
por: Pifferi, Fabien, et al.
Publicado: (2019)

Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease
por: Tissot, Cécile, et al.
Publicado: (2021)

Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study
por: Ng, Kok Pin, et al.
Publicado: (2014)

Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms
por: McGirr, Alexander, et al.
Publicado: (2022)

Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
por: Eikelboom, Willem S., et al.
Publicado: (2022)

Dementia in Southeast Asia: influence of onset-type, education, and cerebrovascular disease
por: Vipin, Ashwati, et al.
Publicado: (2021)

Amyloid-Tau-Neurodegeneration Profiles and Longitudinal Cognition in Sporadic Young-Onset Dementia
por: Vipin, Ashwati, et al.
Publicado: (2022)

Neuropsychiatric symptoms and severity of dementia
por: Caldas, Gustavo Henrique de Oliveira, et al.
Publicado: (2013)

C9orf72 expansions are the most common cause of genetic frontotemporal dementia in a Southeast Asian cohort
por: Tan, Yi Jayne, et al.
Publicado: (2023)

APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia
por: Vipin, Ashwati, et al.
Publicado: (2023)

Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional
por: Vipin, Ashwati, et al.
Publicado: (2021)

Association of physical activity with dementia and cognitive decline in UK Biobank
por: Huang, Xiangyuan, et al.
Publicado: (2023)

Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions
por: Boccella, Serena, et al.
Publicado: (2020)

Multipronged Attack of Stem Cell Therapy in Treating the Neurological and Neuropsychiatric Symptoms of Epilepsy
por: Sadanandan, Nadia, et al.
Publicado: (2021)

Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment
por: Gauthier, Serge, et al.
Publicado: (2018)

Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
por: Cacabelos, Ramon
Publicado: (2020)

Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis
por: Lang, Stefan, et al.
Publicado: (2020)

A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer’s disease
por: Geerts, Hugo, et al.
Publicado: (2013)

Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
por: Lee, Philip E, et al.
Publicado: (2006)

Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
por: Nowrangi, Milap A, et al.
Publicado: (2015)

Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
por: Phan, Stephanie V., et al.
Publicado: (2019)

The importance of co-pathologies on neuropsychiatric symptoms in dementia
por: Gibson, Lucy L., et al.
Publicado: (2022)

NEUROPSYCHIATRIC SYMPTOMS IN PRIMARY CARE PATIENTS WITH DEMENTIA
por: Paul, Constanca, et al.
Publicado: (2022)

The ABCD approach for managing neuropsychiatric symptoms of dementia
por: Siple, Amy
Publicado: (2023)

Facilitating recruitment for dementia research: Insights from an international panel
por: Tam, Mallorie T, et al.
Publicado: (2020)

Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
por: Ba, Maowen, et al.
Publicado: (2016)

What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?
por: Bergamini, Giorgio, et al.
Publicado: (2022)

Anosognosia predicts default mode network hypometabolism and clinical progression to dementia
por: Therriault, Joseph, et al.
Publicado: (2018)

Neuropsychiatric symptoms in patients with vascular dementia in mainland China
por: Jin, Yan-ling, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vuf5blcchlq7b06p3tt6n26r4o